Correction to "Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele"
Cancer. 2026 Mar 15;132(6):e70350.
doi: 10.1002/cncr.70350.